Anthony J. Krick, Vice President, Finance at Milestone Pharmaceuticals Inc., filed an initial statement of beneficial ownership (Form 3) on November 19, 2026, disclosing a derivative security position with an event date of November 10, 2026.
Key Highlights
- Reporting Person: Anthony J. Krick, identified as Vice President, Finance of Milestone Pharmaceuticals Inc. (NASDAQ:MIST).
- Derivative Security: An Employee Share Option (right to buy) covering 100,000 Common Shares at an exercise price of $1.32.
- Expiration Date: The option expires on July 1, 2036.
- Vesting Schedule: One-fourth (1/4th) of the shares vest on May 7, 2027; one thirty-sixth (1/36th) of the remaining shares vest each month thereafter, subject to continued service.
- Ownership Form: The derivative security is held directly (D).
- No Non-Derivative Holdings: Table I reporting non-derivative securities beneficially owned contains no entries.
Krick's Initial Beneficial Ownership Disclosure at Milestone Pharmaceuticals
According to the filing, Anthony J. Krick submitted a Form 3 as a newly reporting person at Milestone Pharmaceuticals Inc., traded on NASDAQ:MIST. The event requiring the statement occurred on November 10, 2026, and the form was filed on November 19, 2026. Krick's address is listed as c/o Milestone Pharmaceuticals Inc., 1111 Dr. Frederik-Philips Blvd., Ste 420, Montreal, Quebec, Canada.
The filing discloses one derivative security position in Table II: an Employee Share Option granting the right to buy 100,000 Common Shares at a conversion or exercise price of $1.32 per share, expiring on July 1, 2026. According to the filing's explanation of responses, one-fourth of the shares subject to the option vest on May 7, 2027, and "one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date."
Table I, covering non-derivative securities beneficially owned, contains no reported holdings. The form was filed by one reporting person and was signed by Joseph Oliveto as Attorney-in-Fact on November 19, 2026.
What Was Disclosed
Anthony J. Krick, Vice President, Finance at Milestone Pharmaceuticals Inc. (NASDAQ:MIST), filed an initial beneficial ownership statement disclosing one Employee Share Option covering 100,000 Common Shares at $1.32, expiring July 1, 2036, with no non-derivative securities reported.




Please wait processing your request...